[
  {
    "ts": null,
    "headline": "Biogen : Update on Regulatory Review of Lecanemab for Early Alzheimer’s Disease by the European Commission",
    "summary": "Update on Regulatory Review of Lecanemab for Early Alzheimer's Disease by the European Commission TOKYO and CAMBRIDGE, Mass., April 14, 2025 - Eisai Co., Ltd. and Biogen Inc. ...",
    "url": "https://finnhub.io/api/news?id=5114922ae4f0909b09f02f693f79099485ab862a35421bf5b9c7126c72432cb1",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1744620605,
      "headline": "Biogen : Update on Regulatory Review of Lecanemab for Early Alzheimer’s Disease by the European Commission",
      "id": 133906528,
      "image": "",
      "related": "BIIB",
      "source": "Finnhub",
      "summary": "Update on Regulatory Review of Lecanemab for Early Alzheimer's Disease by the European Commission TOKYO and CAMBRIDGE, Mass., April 14, 2025 - Eisai Co., Ltd. and Biogen Inc. ...",
      "url": "https://finnhub.io/api/news?id=5114922ae4f0909b09f02f693f79099485ab862a35421bf5b9c7126c72432cb1"
    }
  }
]